Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 63

Results For "biotech"

836 News Found

Covestro and PharmaJet work to take the sting out of vaccinations
Biotech | April 07, 2022

Covestro and PharmaJet work to take the sting out of vaccinations

Makrolon polycarbonate is key to needle-free injections that can stand up to sterilization


BioFluidica to introduce next-generation biomarker isolation platform
Biotech | April 06, 2022

BioFluidica to introduce next-generation biomarker isolation platform

BioFluidica LiquidScan harnesses the power of microfluidics


Agilent joins AMBIC to advance biomanufacturing
Medical Device | April 05, 2022

Agilent joins AMBIC to advance biomanufacturing

Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives


Enteris BioPharma gets featured on its oral drug delivery technology
News | April 05, 2022

Enteris BioPharma gets featured on its oral drug delivery technology

Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability


Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Biotech | April 05, 2022

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D

R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)


CanSinoBIO's Covid-19 mRNA vaccine receives clinical trial approval in China
Biotech | April 04, 2022

CanSinoBIO's Covid-19 mRNA vaccine receives clinical trial approval in China

CanSinoBIO will continue to focus on developing a variety of innovative preventive vaccines in its diversified product pipeline with proprietary technologies, including the inhaled version of its COVID-19 vaccine, Convidecia


Bayer to invest €1.3 billion for driving innovations in life sciences, agriculture segment
News | April 03, 2022

Bayer to invest €1.3 billion for driving innovations in life sciences, agriculture segment

Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024


WHO suspends supply of Covaxin under Covax facility
News | April 03, 2022

WHO suspends supply of Covaxin under Covax facility

WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility


Evonik restructures health care business
News | April 01, 2022

Evonik restructures health care business

The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries


Wipro GE Healthcare launches facility under govt’s PLI scheme
News | April 01, 2022

Wipro GE Healthcare launches facility under govt’s PLI scheme

It is one of the 15 medical device manufacturers approved under the government’s PLI scheme